|  使用说明书

MX273A0_TCH-C260_人多发性骨髓瘤细胞（MM.1S）.pdf

人骨髓瘤细胞，是从一名对类固醇类药物治疗产生耐药性的多发性骨髓瘤患者的外周血中建立的，对地塞米松敏感。该细胞同时存在悬浮生长和轻微贴壁两种状态。

细胞名称：人多发性骨髓瘤细胞

细胞简称：MM.1S

产品货号：TCH-C260

种属来源：人

组织来源：外周血

疾病特征：多发性骨髓瘤

细胞形态：淋巴母细胞样

生长特性：悬浮生长

培养体系：RPMI-1640 ＋10% FBS+1%Glutamax+1% Sodium Pyruvate+1%P/S

配套培养基货号：TCH-G260

传代比例：1:2-1:4，每2-3天换液一次

传代周期：48-96 h

培养条件：气相：95%空气+5%CO2，温度：37℃

冻存条件：60%基础培养基+30%FBS+10%DMSO，液氮储存

质量检测：细菌、真菌、支原体检测均为阴性

参考文献：Goldman-Leikin RE, et al. Characterization of a novel myeloma cell line, MM.1. J. Lab. Clin. Med. 113(3):335-345, 1989. PubMed: 2926241 Greenstein S, et al. Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp. Hematol.: 31:271-282, 2003. PubMed; 12691914 Moalli PA, et al. A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood. 79:213-222, 1992. PubMed: 1728309 Greenstein S, et al. Characterization of the MM.1 human multiple myeloma (MM) cell lines: A model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp. Hematol.: 31:271-282, 2003. PubMed; 12691914

收货当天如何处理细胞？

收到细胞后请务必仔细阅读产品资料，了解细胞相关信息，如贴壁特性 (贴壁/悬浮/半贴壁半悬浮)、细胞形态、培养体系、传代比例和换液频率等。